(Q83943066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

D Reimer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Hubalek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

H Kiefel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Riedle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Skvortsov

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Erdel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Hofstetter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

N Concin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

E Müller-Holzner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

C Marth

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

P Altevogt

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A G Zeimet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

25 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

4038-4049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21516127%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2011.119

29 January 2020

exact match

0 references

cites work

Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Comparative analysis of E2F family member oncogenic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

MethyLight: a high-throughput assay to measure DNA methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Amplification and overexpression of E2F3 in human bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Pharmaceutical management of ovarian cancer : current status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Epithelial growth factor receptor status in primary and recurrent ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.119